Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for an aldehyde possessing alkylating activity as the primary metabolite of cyclophosphamide.

× No keyword cloud information.

12 in total

1. Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide.

Authors: E J Valente; K K Chan; K L Servis
Journal: Pharm Res Date: 1984-03 Impact factor: 4.200

2. Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

Authors: Fei Li; Andrew D Patterson; Constance C Höfer; Kristopher W Krausz; Frank J Gonzalez; Jeffrey R Idle
Journal: Biochem Pharmacol Date: 2010-06-10 Impact factor: 5.858

3. Effect of cyclophosphamide on a local graft-versus-host reaction in the rat: influence of sex, disease and different dosage regimens.

Authors: M W Whitehouse; L Levy; F J Beck
Journal: Agents Actions Date: 1973-06

4. Lymphocyte deactivation by (potential immunosuppressant) alkylating metabolites of cyclophosphamide.

Authors: M W Whitehouse; F W Beck; M M Dröge; R F Struck
Journal: Agents Actions Date: 1974-04

5. [The evaluation of the cyclophosphamide sensitivity of human tumours by determining the incorporation of tritiated uridine and thymidine into the nucleic acids of human tumor cells in vitro in presence of 4-hydroxycyclophosphamide (author's transl)].

Authors: G Bastert; H Schmidt-Matthiesen; G Voelcker; G Peter; H J Hohorst
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1975-09-22

6. Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.

Authors: F D Juma; H J Rogers; J R Trounce
Journal: Eur J Clin Pharmacol Date: 1981 Impact factor: 2.953

7. Preclinical pharmacokinetics and stability of isophosphoramide mustard.

Authors: J J Zheng; K K Chan; F Muggia
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

Review 8. Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells.

Authors: S Madle; G Obe
Journal: Hum Genet Date: 1980 Impact factor: 4.132

9. Excretion patterns of alkylating metabolites in urine following cyclophosphamide treatment of tumor patients: influence of application route, dosage, liver and kidney function.

Authors: G Saul; M Matthias; H Rose; I Pradel
Journal: J Cancer Res Clin Oncol Date: 1979-07-27 Impact factor: 4.553

10. Metabolism of high doses of cyclophosphamide.

Authors: R A Milsted; M Jarman
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333